Evidence map›Paper›PMID 33477309›Full record

Trial reportMolecules (Basel, Switzerland)2021

Tin, Titanium, Tantalum, Vanadium and Niobium Oxide Based Sensors to Detect Colorectal Cancer Exhalations in Blood Samples.

Michele Astolfi, Giorgio Rispoli, Gabriele Anania, Elena Artioli, Veronica Nevoso, Giulia Zonta, Cesare Malagù

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Reproducibility and Repeatability Tests on (SnTiNb)OSensors (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Michele AstolfiDepartment of Physics and Earth Sciences, University of Ferrara, 44122 Ferrara, Italy.ORCID 0000-0002-3578-0946
Giorgio RispoliDepartment of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
Gabriele AnaniaDepartment of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-9255-3312
Elena ArtioliDepartment of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.ORCID 0000-0001-9279-4722
Veronica NevosoDepartment of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.
Giulia ZontaDepartment of Physics and Earth Sciences, University of Ferrara, 44122 Ferrara, Italy.
Cesare MalagùDepartment of Physics and Earth Sciences, University of Ferrara, 44122 Ferrara, Italy.ORCID 0000-0002-8362-5289
University of Ferrara · IT

Funding

SCENT S.r.l. Private FundingUniversity of Ferrara FAR 2016 - 2020; FIR 2016
6 · The paper itself

Abstract

User-friendly, low-cost equipment for preventive screening of severe or deadly pathologies are one of the most sought devices by the National Health Services, as they allow early disease detection and treatment, often avoiding its degeneration. In recent years more and more research groups are developing devices aimed at these goals employing gas sensors. Here, nanostructured chemoresistive metal oxide (MOX) sensors were employed in a patented prototype aimed to detect volatile organic compounds (VOCs), exhaled by blood samples collected from patients affected by colorectal cancer and from healthy subjects as a control. Four sensors, carefully selected after many years of laboratory tests on biological samples (cultured cells, human stools, human biopsies, etc.), were based here on various percentages of tin, tungsten, titanium, niobium, tantalum and vanadium oxides. Sensor voltage responses were statistically analyzed also with the receiver operating characteristic (ROC) curves, that allowed the identification of the cut-off discriminating between healthy and tumor affected subjects for each sensor, leading to an estimate of sensitivity and specificity parameters. ROC analysis demonstrated that sensors employing tin and titanium oxides decorated with gold nanoparticles gave sensitivities up to 80% yet with a specificity of 70%.

Indexed as

Microscopy, Electrochemical, ScanningAdultColorectal NeoplasmsFemaleHumansMaleMetal NanoparticlesNiobiumTantalumTinVanadiumVolatile Organic CompoundsNiobiumTantalumTinVanadiumVolatile Organic Compoundsbloodchemoresistivitycolorectal cancernanostructured sensorstumor markersvolatile organic compounds

Identifiers

PMID33477309
PMCPMC7829789
OpenAlexW3122742526

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.